Halodoc
Also, DeepTek has obtained another 510(k) from the US FDA for its AI solution.
It expects continued long-term growth in the demand for virtual care services post-pandemic.
Halodoc CEO Jonathan Sudharta, discusses his company's growth in the nation during telemedicine's surge in the pandemic.
The campaign comes as Southeast Asia's most populous state battles ongoing health-related hoaxes, disinformation.
Funds from this investing round will be used for the expansion of its solutions and services.
A wrap-up of the key healthtech developments in the APAC region for 2019.